Porosome Therapeutics Holds Global Medicine & Food Security Symposium
SYMPOSIUM PROGRAM&RECORDED PRESENTATIONS
Link to recorded symposium on Global Medicine & Food Security held at the Harvard Club in Boston, MA, USA: https://vimeo.com/1201966363/5060ab548b?fl=pl&fe=ti
| 8:00 am – 8:15 am | Welcome by Guillermo Marmol, CEO, Porosome Therapeutics, Inc., Former Director & Senior Partner, McKinsey & Company, Chair Operating Committee of Perot Systems Corporation. | |
| 8:15 am – 8:45 am | “State of Science at Porosome Therapeutics & MMI” by Bhanu P. Jena, Chairman, Porosome Therapeutics, Inc. & Director, MMI, Distinguished Professor & George E. Palade University Professor, Wayne State University. | |
| 8:45 am – 9:00 am | “Status of Safe & Novel Drugs at Porosome Therapeutics, Inc.” by Juan Ruiz, Member Scientific Advisory Board, Former Deputy Director, FDA Center for Drug Evaluation and Research (CDER). | |
| 9:00 am – 9:15 am | “M&A Deals on Breakthrough Drugs at Porosome Therapeutics, Inc.” by Bob Smith, Senior Commercial Advisor, Porosome Therapeutics, Inc. Most recently, he served on Actelion’s U.S. Executive Leadership Team during the $30 billion acquisition by Johnson & Johnson. | |
| 9:15 am – 9:30 am | Coffee Break | |
| 9:30 am – 10:10 am | “Cryo-EM in Drug Discovery” by Joachim Frank, Chairman, Scientific Advisory Board, Porosome Therapeutics, Inc., Professor, Columbia University, co-recipient of the 2017 Nobel Prize in Chemistry. | |
| 10:10 am –10:50 am | “Facts & Fiction about GMOs” (GMO & Global Food Security) by Richard J. Roberts, Scientific Advisor MMI & NytroPonix, Chief Scientific Officer, New England Biolabs, co-recipient of the 1993 Nobel Prize in Physiology or Medicine. | |
| 10:50 am – 11:05 am | “Flavonoids in Health & Disease” by Robert Flaumenhaft, Member Scientific Advisory Board, Porosome Therapeutics, Inc., Harvard Medical School, Professor & Chief, Division of Hemostasis & Thrombosis. | |
| 11:05 am – 11:20 am | “Breakthrough Cancer Radiotherapy” by Phillip M. Devlin, Member Scientific Advisory Board, Porosome Therapeutics, Inc., Harvard Medical School, Chief of the Division of Brachytherapy in the Department of Radiation Oncology at the Dana-Farber/Brigham and Women’s Cancer Center. | |
| 11:20 am – 11:35 am | “Funding Science & Education” by Daniel A. Walz, COO, MMI & Advisor, Porosome Therapeutics, Inc., Former Vice President of Research, Dean of Graduate School, & Director MD-Ph.D. Program, School of Medicine, Wayne State University. | |
| 11:35 am – 11:45 am | Closing Remarks by Guillermo Marmol, CEO, Porosome Therapeutics, Inc., Former Director & Senior Partner, McKinsey & Company, Chair Operating Committee of Perot Systems Corporation. |